FDA Investigator LCDR Susan E Polifko
LCDR Susan E Polifko has conducted inspections on 83 sites in 1 countries as of 10 Sep 2013. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
83
Last Inspection Date:
10 Sep 2013
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with LCDR Susan E Polifko:
Abdellah El Hajjam,
Alan D Centi,
Alice S Tsao,
Anita R Michael,
Ankur C Patel,
Ann Marie Karnick,
Ann Marie Montemurro,
Anthony A Charity,
Audrey Thereset Uy,
Austin B Appler,
Brandi L Garbutt,
Brandon J Brookens,
Brandy N Lepage,
Brian S Keefer,
Calvin W Edwards,
CDR Michael J Mero,
Cedar H Boakye,
Chamberlain,
Christina K Theodorou,
Craig D Zagata,
Crayton Lee,
Crystal A Harlan,
Cynthia L Rakestraw,
Daniel R Tammariello,
Darlene C Plank Turlington,
David A Oluwo,
David J Hafner,
David L Pearce,
Deborah G Haney Cozzone,
Debra J Bennett,
Debra L Pagano,
Denise M Digiulio,
Dr. Gerald E Poly,
Dr. Mark J Seaton, PhD,
Dr. Yubing Tang,
Edward D Mcdonald,
Eric Rothschild,
Eric S Myskowski,
Erika M Wilkerson,
Gayle S Lawson,
George Pyramides,
Gerald W Kopp,
Gregory E Beichner,
H Ljamilla Selby,
Hala L Selby,
Heriberto Negron Rivera,
Jacob M Dyer,
James M Mason,
James M Odonnell,
James Norman,
James P Mcevoy,
Javier E Santos,
Jeffrey Harrison,
Jessica S Estriplet,
John D Jaworski,
Joseph L Despins, PhD,
Joseph T Dougherty,
Josh Renzo N Ramilo,
Judith A Paterson,
Julianne C Mccullough,
Junho Pak,
Karthik B Iyer,
Karyn M Campbell,
Katelyn Astaub Zamperini,
Kendra L Brooks,
Kevin M Maguire,
Kristen D Evans,
Kristina J Donohue,
Kristina Mjoyce Pittman,
LCDR Margaret Edi Gennaro,
LCDR William H Bender,
Lisa M Bellows,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Luis A Dasta,
Marcus A Ray,
Marjorie L Davis,
Martha Sullivan Myrick,
Mary Davis Lopez,
Mary E Storch,
Matthew R Noonan,
Maureen A Wentzel,
Melissa M Dauksis,
Melissa M Schafer,
Michael A Taylor,
Michael L Casner,
Michele Gottshall,
Mihaly S Ligmond,
Mindy M Chou,
Myrick,
Nikhil Thakur,
Paul L Bellamy,
Prabhu P Raju,
Princess R Campbell,
Rachael O Oyewole,
Rachel C Harrington,
Richard C Cherry,
Robin P Mathew,
Ronald T Colucci,
Rose Ljean Mary,
Sam Pepe,
Sean D Duke,
Sean Y Kassim, PhD,
Shelley L Waring,
Simone E Pitts,
Steven E Kane,
Susan F Laska, MS,
Tarun D Mehta,
Tekalign Wondimu,
Temar Q Williams,
Thomas E Friel,
Thomas J Arista,
Tiffani D Wilson,
Timothy J Schmidt,
Todd J Maushart,
Tonya O Corbin,
Travis R Hunt,
Van Cliff,
Vlada Matusovsky,
William C Brenneman,
Yvins Dezan,
Yvonne C Mcknight,
Yvonne C Wood
LCDR Susan E Polifko's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more